Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | VIVIMEDLAB Vivimed Labs Limited Pharma · Small | VINEETLAB Vineet Laboratories Limited Pharma · Small | MAXHEALTH Max Healthcare Institute Limited Pharma · Large | LOTUSEYE Lotus Eye Hospital and Institute Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 10 | 2 | 35 | 13 |
| Verdict | OVERVALUED | OVERVALUED | WATCHLIST | OVERVALUED |
| Style | OVERVALUED | Distress Watch | WATCHLIST | OVERVALUED |
| Piotroski | 3/9 | 2/9 | 8/9 | 6/9 |
| Valuation | 2/30 | 3/30 | 0/30 | 1/30 |
| Growth | 7/25 | 0/25 | 19/25 | 4/25 |
| Quality | 0/20 | 0/20 | 2/20 | 0/20 |
| Balance Sheet | 4/15 | 0/15 | 5/15 | 4/15 |
| Cash Flow | 3/10 | 7/10 | 4/10 | 4/10 |
| Price | ₹6.15 | ₹33.71 | ₹1,003 | ₹122.39 |
| P/E | — | — | 67.50 | 3065.00 |
| P/B | — | 4.70 | 9.83 | 4.08 |
| ROE | — | -89.50% | 12.70% | 0.13% |
| ROCE | -8.10% | -28.00% | 14.90% | 1.16% |
| Debt / Equity | 0.00 | 3.07 | 0.33 | 0.26 |
| FCF Yield | — | 11.98% | — | — |
| Dividend Y | — | — | 0.15% | — |
| Altman Z | -0.03 | 1.08 | 0.00 | 7.71 |
| Promoter % | 7.57% | 5.98% | 23.71% | 40.14% |
| Mkt Cap (₹Cr) | 51.70 | 66.80 | — | 245.00 |
| Graham # | — | — | ₹84.62 | ₹5.1 |
| Fair PE | 45.0 | 4.2 | 42.0 | 1.0 |
| MoS % | — | — | -672.9% | -308965.7% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startVIVIMEDLAB24
VINEETLAB58
MAXHEALTH93
LOTUSEYE183